Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of sprifermin after microfracture surgery for knee cartilage injury
2012-001431-31Phase 2Completed
- Sponsor
- Merck KGaA
- Start
- Mar 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sprifermin in Knee cartilage injury (3 arms), sponsored by Merck KGaA. Started Mar 2013; status: completed.
02
Drugs
sprifermin
03
Conditions
Knee cartilage injury
Beyond the preview
Go deeper on 2012-001431-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001431-31.